Providing biomarker and bioanalysis expertise to de-risk and optimise drug development.
Key insights to de-risk and optimise your drug development
Synexa’s Scientific Strategies team can help de-risk your development by providing support around key biomarker and bioanalytical considerations.
Selecting the correct targets and biomarkers which demonstrate clear biological effects are essential during early candidate development. Even when entering the clinic, downstream sample processing, assay development and analysis remain key to the ultimate success of the trial.
Whether you are currently working with Synexa’s multidisciplinary lab team or not, the dedicated Scientific Strategies Team can offer standalone consulting support, providing objective, actionable solutions to your biomarker and bioanalytical challenges.
- Bioanalytical troubleshooting – Troubleshooting your current issues and providing technical advice to overcome them
- Biomarker assay validation – Assisting you in validating your biomarker assays
- Biomarker strategy – Developing the right biomarker strategy, including novel biomarker discovery, panel design and platform selection
- Patient selection – Assisting you in patient selection and stratification strategies
- Model selection – Assisting you in model selection and design for translational studies
The Scientific Partner of Choice for Biomarker and Bioanalytical Solutions
Book an introductory consultation call with our team of experts today.